Phenominer Database Results (8 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Formula Value Units SEM SD Method Method Duration Post Insult Time Value Record ID Study ID
LH/Mav renal blood flow rate to kidney weight ratio vehicle control condition then ketamine (20 mg/kg) and thiobutabarbital (75 mg/kg) Issiakhem M, et al., J Cardiovasc Pharmacol. 2008 Mar;51(3):280-5. doi: 10.1097/FJC.0b013e31816299a5. renal blood flow trait male 84 days 8 5.0 ml/min/g 0.3 0.85 ultrasonic flowmeter 0.0 0 102853 2761
LH/Mav renal vascular resistance to kidney weight ratio vehicle control condition then ketamine (20 mg/kg) and thiobutabarbital (75 mg/kg) Issiakhem M, et al., J Cardiovasc Pharmacol. 2008 Mar;51(3):280-5. doi: 10.1097/FJC.0b013e31816299a5. kidney blood vessel physiology trait male 84 days 8 SBP/RBF 33.0 ml/min/g/mmHg 2.0 5.66 ultrasonic flowmeter 0.0 0 102857 2761
LH/Mav renal vascular resistance to kidney weight ratio nifedipine (50 mg/kg/d) (for 63 days) then ketamine (20 mg/kg) and thiobutabarbital (75 mg/kg) Issiakhem M, et al., J Cardiovasc Pharmacol. 2008 Mar;51(3):280-5. doi: 10.1097/FJC.0b013e31816299a5. kidney blood vessel physiology trait male 84 days 7 SBP/RBF 37.0 ml/min/g/mmHg 5.0 13.23 ultrasonic flowmeter 0.0 0 102868 2761
LH/Mav renal vascular resistance to kidney weight ratio hydralazine (75 mg/kg/d) (for 63 days) and controlled hydralazine content drinking water (15 mg/kg/d) (for 63 days) and reserpine (0.75 mg/kg/d) (for 63 days) then ketamine (20 mg/kg) and thiobutabarbital (75 mg/kg) Issiakhem M, et al., J Cardiovasc Pharmacol. 2008 Mar;51(3):280-5. doi: 10.1097/FJC.0b013e31816299a5. kidney blood vessel physiology trait male 84 days 10 SBP/RBF 27.0 ml/min/g/mmHg 2.0 6.32 ultrasonic flowmeter 0.0 0 102869 2761
LH/Mav renal blood flow rate to kidney weight ratio perindopril (1.5 mg/kg/d) (for 63 days) then ketamine (20 mg/kg) and thiobutabarbital (75 mg/kg) Issiakhem M, et al., J Cardiovasc Pharmacol. 2008 Mar;51(3):280-5. doi: 10.1097/FJC.0b013e31816299a5. renal blood flow trait male 84 days 7 5.3 ml/min/g 0.5 1.32 ultrasonic flowmeter 0.0 0 102854 2761
LH/Mav renal vascular resistance to kidney weight ratio perindopril (1.5 mg/kg/d) (for 63 days) then ketamine (20 mg/kg) and thiobutabarbital (75 mg/kg) Issiakhem M, et al., J Cardiovasc Pharmacol. 2008 Mar;51(3):280-5. doi: 10.1097/FJC.0b013e31816299a5. kidney blood vessel physiology trait male 84 days 7 SBP/RBF 23.0 ml/min/g/mmHg 2.0 5.29 ultrasonic flowmeter 0.0 0 102858 2761
LH/Mav renal blood flow rate to kidney weight ratio hydralazine (75 mg/kg/d) (for 63 days) and controlled hydralazine content drinking water (15 mg/kg/d) (for 63 days) and reserpine (0.75 mg/kg/d) (for 63 days) then ketamine (20 mg/kg) and thiobutabarbital (75 mg/kg) Issiakhem M, et al., J Cardiovasc Pharmacol. 2008 Mar;51(3):280-5. doi: 10.1097/FJC.0b013e31816299a5. renal blood flow trait male 84 days 10 4.7 ml/min/g 0.3 0.95 ultrasonic flowmeter 0.0 0 102856 2761
LH/Mav renal blood flow rate to kidney weight ratio nifedipine (50 mg/kg/d) (for 63 days) then ketamine (20 mg/kg) and thiobutabarbital (75 mg/kg) Issiakhem M, et al., J Cardiovasc Pharmacol. 2008 Mar;51(3):280-5. doi: 10.1097/FJC.0b013e31816299a5. renal blood flow trait male 84 days 7 4.9 ml/min/g 0.5 1.32 ultrasonic flowmeter 0.0 0 102855 2761